tirzepatide vs semaglutide weight loss efficacy side effects Tirzepatide: Which GLP-1 Wins for Loss? Semaglutide Vs Tirzepatide Vs Retatrutide

Mounjaro covers two indications: "type 2 diabetes" and "weight loss," which were approved by the National Medical Products Administration in May and July 2024, respectively

Mounjaros product description warns that it could cause thyroid tumors, including cancer

There is also some risk for unmeasured confounding, and factors like bias because of unmeasured variables, dosing differences, using brand as a proxy for target dose, and missing information could have affected the results

Where to inject Three FDA-approved injection sites: abdomen (at least 2 inches from the navel), front of the thigh (middle third), and back of the upper arm

there are many foods I cant eat

Oral semaglutide uses a specialized absorption enhancer called SNAC (sodium N-[8-(2-hydroxybenzoyl) amino] caprylate) that creates a temporary, localized pH change in the stomach, allowing semaglutide to absorb through the gastric lining